Systemic Lupus Erythematosus - Clinical Aspects I

Session Type: ACR Abstract Submissions
Sunday, November 6, 2011: 9:00 AM-6:00 PM
Hall F2 - Poster Hall (McCormick Place West)
Papers:
Restoration of Regulatory T Cells-Th17 Cells Balance in Systemic Lupus Erythematosus Through Vitamin D Supplementation
Benjamin Terrier1, Yoland Schoindre2, Guillaume Geri3, David Saadoun4, Kubéraka Mariampillai5, Michelle Rosenzwajg6, David Klatzmann6, Jean-Charles Piette3, Patrice Cacoub3 and Nathalie Costedoat-Chalumeau3, 1Pitié-Salpêtrière Hospital, Paris, France, 2Foch Hospital, Suresnes, France, 3CHU Pitié-Salpêtrière, Paris, France, 4Department of Internal Medicine and Laboratory I3 “Immunology, Immunopathology, Immunotherapy”, UMR CNRS 7211, INSERM U959, Groupe Hospitalier Pitié-Salpetrière, Université Pierre et Marie Curie, Paris 6, Paris, France, Paris, France, 5Pitié-Salpétrière Hospital, Paris, France, 6Laboratory I3 “Immunology, Immunopathology, Immunotherapy”, UMR CNRS 7211, INSERM U959, Paris, France
Safety Profile of Belimumab, a B-Lymphocyte Stimulator–Specific Inhibitor, in Phase 2 and 3 Clinical Trials of Patients with Active Systemic Lupus Erythematosus
D.J. Wallace1, S. Navarra2, M. Petri3, A. Gallacher4, R. Gúzman5, M. Thomas6, R.A. Furie7, O. Zamani8, R.A. Levy9, R.F. van Vollenhoven10, S. Cooper11, Z.J. Zhong11, W. Freimuth11, L. Pineda11, R. Cervera12 and BLISS-52 and -76 and LBSL02/99 Study Groups13, 1Cedars-Sinai/UCLA, Los Angeles, CA, 2University of Santo Tomas Hospital, Manila, Philippines, 3Johns Hopkins University School of Medicine, Baltimore, MD, 4Hospital Británico de Buenos Aires, Buenos Aires, Argentina, 5IDEARG, SaludCoop, Bogotá, Colombia, 6Kerala Institute of Medical Sciences, Kerala, India, 7North Shore-LIJ Health System, Lake Success, NY, 8Rheumazentrum Favoriten, Wien, Austria, 9Hospital Universitário Pedro Ernesto, Rio de Janeiro, Brazil, 10The Karolinska Institute, Stockholm, Sweden, 11Human Genome Sciences, Inc., Rockville, MD, 12Hospital Clinic, Barcelona, Spain, 13Multicenter
Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients with Systemic Lupus Erythematosus
Chi Chiu Mok1, Pak To Chan1, Ling Yin Ho2, Ka Lung Yu1 and Chi Hung To1, 1Tuen Mun Hospital, Hong Kong, Hong Kong, 2Tuen Mun Hospital, Hong Kong SAR, Hong Kong
A Risk Management Program Led by a Nurse Improves Cardiovascular and Osteoporosis Risk Management in a Specialized Lupus Clinic
Anne Cymet1, Carolina Landolt-Marticorena2, Dafna D. Gladman3, Paul R. Fortin2 and Murray B. Urowitz2, 1University Health Network, Toronto, ON, 2Toronto Western Hospital and University of Toronto, Toronto, ON, 3Toronto Western Hospital, University of Toronto, Toronto, ON
Antimalarials: A Window of Opportunity to Improve the Influenza A/H1N1 Vaccine Response in Lupus Patients Under Immunosuppressive Agents
Eduardo F. Borba1, Carla G.S. Saad1, Sandra G. Pasoto1, Ana L. G. Calich1, Nadia E. Aikawa1, Ana C. M. Ribeiro2, Julio C. B. Moraes2, Elaine P. Leon1, Luciana P.C. Seguro1, Lissiane K. N. Guedes1, Clovis A. Silva1, Celio Goncalves2, Ricardo Fuller3, Suzimara A. Oliveira1, Maria A. Ishida4, Alexander R. Precioso5 and Eloisa Bonfa6, 1University of Sao Paulo, Sao Paulo, Brazil, 2Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 3University of Sao Paulo, São Paulo, Brazil, 4Adolfo Lutz Institute, Sao Paulo, Brazil, 5Butantan Institute, Sao Paulo, Brazil, 6Faculdade de Medicina da Universidade de São Paulo (FMUSP), Sao Paulo, Brazil
Defensins and Cardiovascular Disease In Systemic Lupus Erythematosus
Stefan Vordenbäumen, Oliver Sander, Ellen Bleck, Matthias Schneider and Rebecca Fischer-Betz, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Differences Between Male and Female Systemic Lupus Erythematosus In a Multi-Ethnic Population
Tan Tze Chin1, Hong Fang1, Laurence S. Magder2 and Michelle Petri1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Maryland, Baltimore, MD
Sustained Disease Improvement and Safety Profile Over the 1500 Patient-Year Experience (6 years) with Belimumab in Patients with Systemic Lupus Erythematosus 
J.T. Merrill1, R.A. Furie2, D.J. Wallace3, W. Stohl4, W. Winn Chatham5, A. Weinstein6, J. Mckay7, E.M. Ginzler8, Z.J. Zhong9, L. Pineda9, J. Klein9, W. Freimuth9, M. Petri10 and LBSL02/99 Study Group11, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2North Shore-LIJ Health System, Lake Success, NY, 3Cedars-Sinai/UCLA, Los Angeles, CA, 4USC/Keck School of Medicine, Los Angeles, CA, 5University of Alabama at Birmingham, Birmingham, AL, 6Washington Hospital Center, Washington, DC, 7Oklahoma State University Center for Health Sciences, Tulsa, OK, 8SUNY Downstate Medical Center, Brooklyn, NY, 9Human Genome Sciences, Inc., Rockville, MD, 10Johns Hopkins University School of Medicine, Baltimore, MD, 11Multicenter
Association between B-Cell Activating Factor Gene Expression and Disease Characteristics in Systemic Lupus Erythematosus
Michelle Petri1, Wenzheng Hu1, Hong Fang1, Jie Xu1, Jadwiga Bienkowska2, Norm Allaire2, John Carulli2 and Matthew D. Linnik3, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Biogen Idec Inc., Cambridge, MA, 3Biogen Idec Inc., Solana Beach, CA
Decreased Breast Cancer Risk In SLE: Can a Genetic Basis Be Determined?
Sasha Bernatsky1, Douglas Easton2, Alison M. Dunning2, Rosalind Ramsey-Goldman3, Caroline Gordon4, William Foulkes5, Kyriaki Michailidou2 and Ann E. Clarke6, 1McGill UHC/RVH, Montreal, QC, 2University of Cambridge, United Kingdom, 3Northwestern University, Chicago, IL, 4University of Birmingham, Birmingham, United Kingdom, 5McGill University, Montreal, QC, 6Research Institute of the McGill Univ. Health, Montreal, QC
Cystatin C Is Associated with Inflammation but Not Atherosclerosis In Systemic Lupus Erythematosus
Ratchaya Lertnawapan1, Aihua Bian2, Young Hee Rho1, Paolo Raggi3, Annette Oeser4, Joseph F. Solus4, Tebeb Gebretsadik2, Ayumi Shintani2 and C. Michael Stein4, 1Div.of Clinical Pharmacology and Rheumatology, Dept.of Medicine and Pharmocology, School of Medicine, Vanderbilt University, Nashville, TN, 2Vanderbilt Medical Center, Nashville, TN, 3Div.of Cardiology, Emory University, Atlanta, GA, 4Vanderbilt University, Nashville, TN
A New 30-Year Cardiovascular Risk Prediction Score Does Not Differ in Women with Systemic Lupus Erythematosus and Control Subjects
Vivian K. Kawai1, Joseph F. Solus1, Annette Oeser1, Young Hee Rho1, Paolo Raggi2, Aihua Bian3, Tebeb Gebretsadik3, Ayumi Shintani3 and C. Michael Stein1, 1Vanderbilt University, Nashville, TN, 2Div.of Cardiology, Emory University, Atlanta, GA, 3Vanderbilt Medical Center, Nashville, TN
Development of Damage and Death in a Large Cohort of SLE Patients
Chee-Seng Yee1, Deva Situnayake2, Simon J. Bowman3, Veronica Toescu1, Richard A. Hickman1 and Caroline Gordon1, 1University of Birmingham, Birmingham, United Kingdom, 2Sandwell and West Birmingham NHS Trust, Birmingham, United Kingdom, 3Selly Oak & Queen Elizabeth Hospitals Birmingham, Birmingham, United Kingdom
Depression in Systemic Lupus Erythematosus, Dependent or Independent of Severity of Disease
Eric van Exel1, Jonathan Jacobs1, Lindy-Anne Korswagen1, Alexandre Voskuyl1, Max Stek1, Joost Dekker2 and Irene Bultink1, 1VU University Medical Center, Amsterdam, Netherlands, 2Reade, Centre for Rehabilitation and Rheumatology, VU University Medical Centre, Department of Rehabilitation Medicine, EMGO Institute and Department of Psychiatry, Amsterdam, Netherlands
A Prospective Study of Seizures in Systemic Lupus Erythematosus
John G. Hanly1, Murray B. Urowitz2, Li Su3, Caroline Gordon4, Sang-Cheol Bae5, Jorge Sanchez-Guerrero6, Juanita Romero-Diaz7, Daniel Wallace8, Ann Clarke9, Sasha Bernatsky10, E.M. Ginzler11, Joan T. Merrill12, David A. Isenberg13, Anisur Rahman13, M. Petri14, Paul R. Fortin15, Dafna D. Gladman16, Ian N. Bruce17, Kristjan Steinsson18, M.A. Dooley19, Munther A. Khamashta20, Graciela S. Alarcon21, Barri J. Fessler21, Rosalind Ramsey-Goldman22 and Susan Manzi23, 1Dalhousie University, Halifax, NS, 2Toronto Western Hospital and University of Toronto, Toronto, ON, 3MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge, UK, Cambridge, United Kingdom, 4University of Birmingham, Birmingham, United Kingdom, 5Hanyang University Hospital for Rheumatic Diseases, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 6Mount Sinai Hospital/University Health Network, Toronto, ON, 7INCMNSZ, Mexico city, Mexico, 8Cedars-Sinai/UCLA, Los Angeles, CA, 9Montreal General Hospital, Montreal, QC, 10McGill UHC/RVH, Montreal, QC, 11SUNY-Downstate Medical Center, Brooklyn, NY, 12Oklahoma Medical Research Foundation, Oklahoma City, OK, 13University College London, London, United Kingdom, 14Johns Hopkins University School of Medicine, Baltimore, MD, 15Toronto Western Hospital, Toronto, ON, 16Toronto Western Hospital, University of Toronto, Toronto, ON, 17A, Manchester, United Kingdom, 18Landspital Univ Hospital, Reykjavik, Iceland, 19University of North Carolina at Chapel Hill, Chapel Hill, NC, 20Lupus Research Unit, The Rayne Institute, Kings College London School of Medicine, London, United Kingdom, 21University of Alabama at Birmingham, Birmingham, AL, 22Northwestern University Feinberg School of Medicine, Chicago, IL, 23Allegheny Singer Research Institute, Pittsburgh, PA
Predictors of Seizures in Systemic Lupus Erythematosus
John G. Hanly1, Murray B. Urowitz2, Li Su3, Caroline Gordon4, Sang-Cheol Bae5, Jorge Sanchez-Guerrero6, Juanita Romero-Diaz7, Daniel Wallace8, Ann E. Clarke9, Sasha Bernatsky10, E.M. Ginzler11, Joan T. Merrill12, David A. Isenberg13, Anisur Rahman13, M. Petri14, Paul R. Fortin15, Dafna D. Gladman16, Ian N. Bruce17, Kristjan Steinsson18, M.A. Dooley19, Munther A. Khamashta20, Graciela S. Alarcon21, Barri J. Fessler21, Rosalind Ramsey-Goldman22 and Susan Manzi23, 1Dalhousie University and Capital Health, Halifax, NS, 2Toronto Western Hospital and University of Toronto, Toronto, ON, 3MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge, UK, Cambridge, United Kingdom, 4University of Birmingham, Birmingham, United Kingdom, 5Hanyang University Hospital for Rheumatic Diseases, Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, 6Mount Sinai Hospital/University Health Network, Toronto, ON, 7INCMNSZ, Mexico city, Mexico, 8Cedars-Sinai/UCLA, Los Angeles, CA, 9Research Institute of the McGill Univ. Health, Montreal, QC, 10McGill UHC/RVH, Montreal, QC, 11SUNY-Downstate Medical Center, Brooklyn, NY, 12Oklahoma Medical Research Foundation, Oklahoma City, OK, 13University College London, London, United Kingdom, 14Johns Hopkins University School of Medicine, Baltimore, MD, 15Toronto Western Hospital, Toronto, ON, 16Toronto Western Hospital, University of Toronto, Toronto, ON, 17A, Manchester, United Kingdom, 18Landspital Univ Hospital, Reykjavik, Iceland, 19University of North Carolina at Chapel Hill, Chapel Hill, NC, 20Lupus Research Unit, The Rayne Institute, Kings College London School of Medicine, London, United Kingdom, 21University of Alabama at Birmingham, Birmingham, AL, 22Northwestern University Feinberg School of Medicine, Chicago, IL, 23Allegheny Singer Research Institute, Pittsburgh, PA
Plasma Levels of Osteopontin Identify Patients At Risk for Organ Damage in Systemic Lupus Erythematosus
Ornella J. Rullo1, Jennifer MP Woo1, Alice DC Hoftman1, Miriam F. Parsa1, David Elashoff2, Paul Maranian3, Jennifer M. Grossman4, Bevra H. Hahn4, Maureen A. McMahon3, Deborah K. McCurdy1 and Betty P. Tsao3, 1Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, 2University of California, Los Angeles, Los Angeles, CA, 3David Geffen School of Medicine University of California Los Angeles, Los Angeles, CA, 4UCLA David Geffen School of Medicine, Los Angeles, CA
All-Trans Retinoic Acid Sustains the Stability and Function of Natural Regulatory T Cells From Human and Patients with SLE
Qin Lan1, Julie Wang1, Hui-Ming Fan2, David Brand3, Hejian Zou4, Zhong-Min Liu2 and Song G. Zheng1, 1University of Southern California, Los Angeles, CA, 2Shanghai East Hospital, Tonji University, Shanghai, China, 3VA Medical Center, Memphis, TN, 4Huashan Hospital, Shanghai, China
Monocyte Chemoattractant Protein-1 and Pentraxin in Systemic Lupus Erythematosus
Adnan Kiani1, Thor Ueland2, Pal Aukrust2, Laurence S. Magder3, Ivana Hollan4 and Michelle Petri1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2The Oslo University, Oslo, Norway, 3University of Maryland, Baltimore, MD, 4Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway
Increase In Vitamin D Improves Urine Protein/Creatinine Ratio and Complement In Systemic Lupus Erythematosus
Michelle Petri1, Kayode J. Bello1, Hong Fang1 and Laurence S. Magder2, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Maryland, Baltimore, MD
The Contribution of Cell Bound Complement Activation Products to the Diagnosis of Systemic Lupus Erythematosus
Kenneth C. Kalunian, UCSD School of Medicine, La Jolla, CA, W. Chatham, UAB Arthritis Clinical Intervention Program, Birmingham, AL, Elena M. Massarotti, Brigham and Women's Hospital, Boston, MA, Cole Harris, Exagen Diagnostics, R.A. Furie, North Shore-LIJ Health System, Lake Success, NY, Jill P. Buyon, NYU School of Medicine, New York, NY, Eliza F. Chakravarty, Stanford University, Palo Alto, CA, Emily C. Somers, University of Michigan, Ann Arbor, MI, Puja Chitkara, SDAMC, San Diego, CA, Rachel L. Gross, Albert Einstein College of Medicine, New York, NY, Kyriakos A. Kirou, Mary Kirkland Center for Lupus Care, Hospital for Special Surgery, New York, NY, Joyce Reyes-Thomas, Albert Einstein College of Med, Bronx, NY, Rosalind Ramsey-Goldman, Northwestern University Feinberg School of Medicine, Chicago, IL, Christine Hsieh, University of Chicago, Chicago, IL, Chaim Putterman, Albert Einstein College of Medicine, Bronx, NY, Thierry Dervieux, Exagen Diagnostics, Albuquerque, NM and A. Weinstein, Washington Hospital Center, Washington, DC
Predictors of Organ Damage At the Time of Systemic Lupus Erythematosus Diagnosis, and of Rates of Increase in Damage After Diagnosis
Sneha Purvey1, Hong Fang1, Laurence S. Magder2 and Michelle Petri1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Maryland, Baltimore, MD
Time to Recovery From Proteinuria in Lupus Nephritis Patients Receiving Standard of Care Treatment
Zahi Touma1, Murray B. Urowitz1, Dominique Ibanez1 and Dafna D. Gladman2, 1Toronto Western Hospital and University of Toronto, Toronto, ON, 2Toronto Western Hospital, University of Toronto, Toronto, ON
Proposal for a Reliable and Feasible Algorithm for the Identification of Antinuclear Antibodies
Kaline M.C. Pereira, Alessandra Dellavance and Luis E. C. Andrade, Universidade Federal de São Paulo and Fleury Health and Medicine Laboratories, Sao Paulo, Brazil
Longitudinal Assessment of SLE Disease Activity: BILAG-2004, SLEDAI-2000 or Both?
Chee-Seng Yee1, Caroline Gordon1, David A. Isenberg2, Bridget Griffiths3, Lee- Suan Teh4, Ian N. Bruce5, Yasmeen Ahmad6, Anisur Rahman2, Athiveeraramapandian Prabu1, Mohammed Akil7, Neil J. McHugh8, Christopher Edwards9, DP. D'Cruz10, Munther A. Khamashta11 and Vernon Farewell12, 1University of Birmingham, Birmingham, United Kingdom, 2University College London, London, United Kingdom, 3Freeman Hospital, Newcastle Upon Tyne, United Kingdom, 4Royal Blackburn Hospital, Blackburn, United Kingdom, 5A, Manchester, United Kingdom, 6The Department of Rheumatology, Betsi Cadwaladr University Health Board (West), Llandudno, LL30 1LB, UK, Wales, United Kingdom, 7Sheffield Center Rheumatic Dis, Sheffield South Yorkshire, United Kingdom, 8Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 9Southhampton General Hospital, Southampton, United Kingdom, 10St. Thomas' Hospital, London, United Kingdom, 11Lupus Research Unit, The Rayne Institute, Kings College London School of Medicine, London, United Kingdom, 12MRC Biostatistics Unit, Cambridge, United Kingdom
Post Hoc British Isles Lupus Assessment Group Index Mucocutaneous Organ Domain Item Analysis of Systemic Lupus Erythematosus Patients Treated in Phase 3 Belimumab Clinical Trials
Susan Manzi1, Dafna Gladman2, Sandra Navarra3, Jorge Sanchez-Guerrero4, David D'Cruz5, William Freimuth6, Z. John Zhong6, Greg Keenan6 and BLISS-52 and BLISS-76 Study Groups7, 1Allegheny Singer Research Institute, Pittsburgh, PA, 2Toronto Western Hospital, Toronto, ON, 3University of Santo Tomas Hospital, Manila, Philippines, 4Mount Sinai Hospital/University Health Network, Toronto, ON, 5St. Thomas' Hospital, London, United Kingdom, 6Human Genome Sciences, Inc., Rockville, MD, 7Multicenter
Vascular Cell Adhesion Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin in Systemic Lupus Erythematosus
Adnan Kiani1, Hong Fang1, Tianfu Wu2, Laurence S. Magder3, Chandra Mohan4 and Michelle Petri1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Texas, Southwestern Medical Center at Dallas, Dallas, TX, 3University of Maryland, Baltimore, MD, 4University of Texas Southwestern Medical Center, Dallas, TX
Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry: Prevalence and Risk Factors of Pulmonary Arterial Hypertension and Interstitial Lung Disease in Chinese Patients with Systemic Lupus Erythematosus
Qian Wang Jr.1, Mengtao Li1, Jiuliang Zhao1, Xiaofeng Zeng2 and Chinese SLE Treatment and Research Group (CSTAR)3, 1Peking Union Medical College Hospital, Beijing, China, 2Peking Union M edical College Hospital , Peking Union M edical College,, Beijing, China, 3Beijing, China
The BILAG-2004 Systems Tally - a Novel Way of Analysing the BILAG-2004 Scores
Chee-Seng Yee1, Caroline Gordon1, David A. Isenberg2, Bridget Griffiths3, Lee- Suan Teh4, Ian N. Bruce5, Yasmeen Ahmad6, Anisur Rahman2, Athiveeraramapandian Prabu1, Mohammed Akil7, Neil J. McHugh8, Christopher Edwards9, DP. D'Cruz10, Munther A. Khamashta11 and Vernon Farewell12, 1University of Birmingham, Birmingham, United Kingdom, 2University College London, London, United Kingdom, 3Freeman Hospital, Newcastle Upon Tyne, United Kingdom, 4Royal Blackburn Hospital, Blackburn, United Kingdom, 5A, Manchester, United Kingdom, 6The Department of Rheumatology, Betsi Cadwaladr University Health Board (West), Llandudno, LL30 1LB, UK, Wales, United Kingdom, 7Sheffield Center Rheumatic Dis, Sheffield South Yorkshire, United Kingdom, 8Royal National Hospital, Bath, United Kingdom, 9University of Southampton, Southampton, United Kingdom, 10St. Thomas' Hospital, London, United Kingdom, 11Lupus Research Unit, The Rayne Institute, Kings College London School of Medicine, London, United Kingdom, 12MRC Biostatistics Unit, Cambridge, United Kingdom
Seasonal Variation In the Activity of Systemic Lupus Erythematosus
Alí Duarte-García1, Hong Fang1, Chi Hung To2, Laurence S. Magder3 and Michelle Petri1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Chelsea Heights, Hong Kong, Hong Kong, 3University of Maryland, Baltimore, MD
Predictors of Corticosteroid Tapering in Systemic Lupus Erythematosus Patients
Zaki Abou Zahr1, Hong Fang1, Laurence S. Magder2 and Michelle Petri1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Maryland, Baltimore, MD
Results of a French Multicenter Randomized Prospective Study (the PLUS Study) on Reduction of Systemic Lupus Erythematosus Flares Through Adaptation of the Dosage of Hydroxychloroquine to Its Whole-Blood Concentration
Nathalie Costedoat-Chalumeau1, L. Galicier1, O. Aumaitre1, C. Francès1, Véronique Le Guern2, F. Lioté1, A. Smail1, N. Limal1, L. Perard1, H. Desmurs-Clavel1, B. Asli1, C. Grandpeix1, Olivier Pourrat3, F. Ackermann1, T. Papo1, B. Brihaye1, O. Fain1, J. Stirnemann1, Moez Jallouli1, J. Cohen1, Marie-Laure Tanguy1, Js Hulot1, L. Musset1, Zahir Amoura1 and . the investigators of the PLUS study1, 1CHU Pitié-Salpêtrière, Paris, France, 2Cochin Hospital, Paris, France, 3CHU poitiers, Poitiers, France
Biologics use in SLE in 23 Centers - Data from the International Registry for Biologics In SLE (IRBIS)
R.F. van Vollenhoven1, Søren Jacobsen2, Daniel Wallace3, John G. Hanly4, Michelle Petri5, David A. Isenberg6, Sasha Bernatsky7, Sang-Cheol Bae8, Manuel Ramos-Casals9, Guillermo Ruiz-Irastorza10, Francisco J. García-Hernández11, Luis Saez12, José Luis Callejas13, Javier Rascón14, Enrique de Ramón15, Mª Mar Ayala-Gutiérrez15, Maite Camps15, Melinda Mild16, Murat Inanç17, Bahar Artim-Esen17, Rosalind Ramsey-Goldman18, Christine A. Peschken19, Danilo Squatrito20, László Kovács21, Andrea Doria22, Zoltan Szekanecz23, Elisa Gremese24 and Emilia I. Sato25, 1Karolinska University Hospital, Stockholm, Sweden, 2Copenhagen University Hospital, Copenhagen, Denmark, 3Cedars-Sinai/UCLA, Los Angeles, CA, 4Dalhousie University and Capital Health, Halifax, NS, 5Johns Hopkins Hospital, Baltimore, MD, 6University College London, London, United Kingdom, 7McGill UHC/RVH, Montreal, QC, 8Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 9Hospital Clínic, Barcelona, Spain, 10Hospital de Cruces, Bizkaia, Spain, 11Hospital Virgen del Rocío, Sevilla, Spain, 12Hospital Miguel Servet, Zaragoza, Spain, 13Hospital San Cecilio, Granada, Spain, 14Hospital Son Dureta, Palma de Mallorca, Spain, 15Hospital Carlos Haya, Málaga, Spain, 16Karolinska Institutet, Stockholm, Sweden, 17Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey, 18Northwestern University Feinberg School of Medicine, Chicago, IL, 19Univ of Manitoba, Winnipeg, MB, 20Careggi Hospital- Florence, Florence, Italy, 21University of Szeged, Szeged, Hungary, 22University of Padova, Padova, Italy, 23University of Debrecen Medical and Health Sciences Center, Debrecen, Hungary, 24Rheumatology Unit, Catholic University, Roma, Italy, 25Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil
Differences in Autoantibody Profiles, Disease Activity (SLEDAI) and Damage (SDI) Scores Between Childhood-Onset Lupus and Adult-Onset Lupus: A Meta-Analysis
Brieanna Livingston, University of Western Ontario, London, ON, Ashley Bonner, McMaster University, Hamilton, ON and Janet E. Pope, St. Joseph's Health Care, University of Western Ontario, London, ON
Why Do Lupus Patients Go to the Emergency Department in the United States?
Marina Scolnik1, Ajitha Mannalithara2, Enrique R. Soriano1 and Gurkirpal Singh2, 1Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2Stanford University School of Medicine, Palo Alto, CA
Achieving Consensus on Quality Indicators for Pediatric Systemic Lupus Erythematosus
Joshua D. Pendl1, Matthew C. Hollander2, Shannen L. Nelson1, Xolti Morgan3, Nicolino Ruperto4, Michael W. Beresford5, Marisa Klein-Gitelman6, Marilynn G. Punaro7, Anne M. Stevens2, Tadej Avcin8, Graciela Espada9, Tsz-Leung Lee10, Yu-Lung Lau10, Jennifer L. Huggins1, Esi Morgan Dewitt1 and Hermine Brunner1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Seattle Children's Hospital, Seattle, WA, 3University of Cincinnati, Cincinnati, OH, 4PRINTO-IRCCS, Genova, Italy, 5Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, 6Children's Memorial Hospital, Chicago, IL, 7Texas Scottish Rite Hospital, Dallas, TX, 8University Children's Hospital Ljubljana, Ljubljana, Slovenia, 9Childrens Hosp Ricardo Gutierrez, Buenos Aires, Argentina, 10The University of Hong Kong, Hong Kong, Hong Kong
Effect of Hydroxychloroquine and Statin Therapy on Pro-Inflammatory Cytokines and  Disease Activity in a Lupus Cohort
Rohan Willis1, Praveen Jajoria1, Brock E. Harper1, Emilio B. Gonzalez1, M. Petri2, Ehtisham Akhter2, Hong Fang2 and Silvia S. Pierangeli1, 1University of Texas Medical Branch, Galveston, TX, 2Johns Hopkins University School of Medicine, Baltimore, MD
Increased Disease Activity Measure in Systemic Lupus Erythematosus Is Adversely Associated with Pregnancy and Pregnancy Outcomes
Lisa A. Davis1, Vincent M. Davis1, Laura Trupin2, Jinoos Yazdany3, Edward Yelin4 and Joann Zell5, 1Univ of Colorado School of Med, Aurora, CO, 2UC San Francisco, San Francisco, CA, 3University of California San Francisco, San Francisco, CA, 4UCSF, San Francisco, CA, 5National Jewish Health, Denver, CO
Urinary λ Free Light Chain Concentration Is Associated with Disease Activity and Response to Treatment in Proliferative Lupus Nephritis
Masanori Hanaoka, Takahisa Gono, Yasushi Kawaguchi, Hirotaka Kaneko, Yumi Koseki, Yasuhiro Katsumata, Kae Takagi, Hisae Ichida, Sayumi Baba, Yuko Okamoto, Yuko Ota, Sayuri Kataoka and Hisashi Yamanaka, Tokyo Women's Medical University, Tokyo, Japan
Lymphoproliferative Disorders in Patients with Systemic Lupus Erythematosus At the University of Michigan
Jason S. Knight and Emily C. Somers, University of Michigan, Ann Arbor, MI
Disease Activity and Quality of Life in Refractory Cutaneous Lupus Erythematosus Patients Initiated on Immunosuppressive Therapy
Aileen Y. Chang1, Elizabeth Ghazi2, Joyce Okawa1 and Victoria P. Werth1, 1Perelman School of Medicine at the University of Pennsylvania and Philadelphia V.A. Medical Center, Philadelphia, PA, 2UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ
Higher Education Level is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort
Rachel L. Gross, Dawn M. Wahezi, Chaim Putterman and Irene Blanco, Albert Einstein College of Medicine, Bronx, NY
Distribution of Urine Protein/Creatinine Ratio by Urinalysis Protein Dipstick Score In Systemic Lupus Erythematosus
Hong Fang1, Laurence S. Magder2 and Michelle Petri1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Maryland, Baltimore, MD
Avoidance of Major Bleeding Complications Post Renal Biopsy In Lupus Nephritis Patients with Co-Existing Antiphospholipid Syndrome
Natasha Jordan, Ahlem I. Chaib, Shirish Sangle, Fahim Tungekar, Munther Khamastha, Tarun Sabharwal, Ian Abbs and David P. D'Cruz, Louise Coote Lupus Unit, St Thomas' Hospital, London, United Kingdom
Serum Macrophage Migration Inhibitory Factor In Systemic Lupus Erythematosus with Long-Term Remission and Its Relationship to Chronic Glucocorticoid Exposure
Yoko Wada1, Hiroe Sato1, Daisuke Kobayashi1, Takeshi Nakatsue1, Shuichi Murakami1, Takeshi Kuroda1, Masaaki Nakano2 and Ichiei Narita1, 1Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 2Niigata University School of Medicine, Niigata, Japan
Association of Lupus Nephritis Class with Poor Longterm Outcomes
Michelle Petri and Hong Fang, Johns Hopkins University School of Medicine, Baltimore, MD
Ultrasound Assessment of Erosive hand arthritis In Systemic Lupus Erythematosus
Elisabeth M.A Ball, Musgrave Park Hospital/Queens' University, Belfast, United Kingdom, Madeleine Rooney, Arthritis Research Group, Queen's University, Belfast, United Kingdom and Aubrey Bell, Musgrave Park Hospital/Queens' University, Belfast, Ireland
Human CD8 regulatory T cells generated Ex-Vivo have Potent Protective Activity In Vivo
Qin Lan, Stephanie Pan, Dixon Gray, Julie Wang, Song G. Zheng and David A. Horwitz, USC Keck School of Medicine, Los Angeles, CA
Higher Frequency and Worse Outcome of Lupus Nephritis in Korean Male
Jiwon Hwang1, Jaejoon Lee1, Joong Kyong Ahn2, Chan Hong Jeon3, Hoon-Suk Cha1 and Eun-Mi Koh1, 1Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Soonchunhyang University College of Medicine, Bucheon, South Korea
Impact of Health Literacy on Treatment Adherence and Clinical Outcomes in Patients with Systemic Lupus Erythematosus
Maria F. Marengo1, Michael A. Kallen1, Sofia De Achaval2, Vanessa Cox1, Araceli Garcia3, Marsha Richardson4 and Maria E. Suarez-Almazor5, 1UT MD Anderson Cancer Center, Houston, TX, 2U.T. MD Anderson Cancer Center, Houston, TX, 3UT MD Anderson, Houston, 4UT MD Anderson, Houston, TX, 5University of Texas. M.D Anderson Cancer Center, Houston, TX
Risk Factors to Predict the Development of Chronic Kidney Disease In Patients with Lupus Nephritis
Dong-Jin Park1, Sung-Ji Lee1, Tae-Jong Kim2, Yong-Wook Park2 and Shin-Seok Lee1, 1Chonnam National University Medical School, Gwangju, South Korea, 2Chonnam National University Medical School and Hospital, Gwangju, South Korea
Emergency Room Visits and Hospitalizations in Systemic Lupus Erythematosus
Jie Xu, Hong Fang and Michelle Petri, Johns Hopkins University School of Medicine, Baltimore, MD
Eltrombopag As Steroid Sparing Therapy for Immune Thrombocytopenic Purpura (ITP) in Systemic Lupus Erythemathosus (SLE), Report of Three Cases
Marie Claire Maroun1, Rosanne Ososki2, Judith Andersen1, Frank B. Vasey1 and J. Patricia Dhar1, 1Wayne State University, Detroit, MI, 2Detroit Medical Center, Detroit, MI
How Does Cutaneous Lupus Disease Area and Severity Index (CLASI) Compare with Physician Assessments of Cutaneous Activity and Damage in Lupus?
Meenakshi Jolly, Nazia Kazmi, Rachel A. Mikolaitis and Joel A. Block, Rush University Medical Center, Chicago, IL
Clinical Outcomes In SLE Patients Since the introduction of the 2003 ISN/RPS Classification of Lupus Nephritis
Natasha Jordan, Shirish Sangle, Yousuf Karim, Fahim Tungekar, Ian Abbs and David P. D'Cruz, Louise Coote Lupus Unit, St Thomas' Hospital, London, United Kingdom
See more of: ACR Abstract Submissions

To see other sessions for this day, use the date buttons to the left.